Utility of the provocation coupled with the drug reintroduction test in the diagnosis of a hypersensitivity reaction to fixed-dose combination (FDC) of anti-TB drugs
A. Sana (Sousse, Tunisia), O. Asma (Sousse, Tunisia), B. Rahma (Kairouan, Tunisia), B. Wafa (Sousse, Tunisia), K. Asma (Sousse, Tunisia), K. Amani (Kairouan, Tunisia), G. Imen (Sousse, Tunisia), A. Ahmed (Sousse, Tunisia), H. Abdelaziz (Sousse, Tunisia)
Source: International Congress 2022 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and NTM
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Sana (Sousse, Tunisia), O. Asma (Sousse, Tunisia), B. Rahma (Kairouan, Tunisia), B. Wafa (Sousse, Tunisia), K. Asma (Sousse, Tunisia), K. Amani (Kairouan, Tunisia), G. Imen (Sousse, Tunisia), A. Ahmed (Sousse, Tunisia), H. Abdelaziz (Sousse, Tunisia). Utility of the provocation coupled with the drug reintroduction test in the diagnosis of a hypersensitivity reaction to fixed-dose combination (FDC) of anti-TB drugs. 4090
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|